Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia.

Authors:
Trunfio M; Portesani F; Vicinanza S; Nespoli P; Traverso F and 4 more

Journal:
Lung

Publication Year: 2022

DOI:
10.1007/s00408-022-00566-7

PMCID:
PMC9483268

PMID:
36114845

Journal Information

Full Title: Lung

Abbreviation: Lung

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declarations Competing interestThe authors declare no competing interests. Conflict of interestThe authors have no relevant financial or non-financial interests to disclose. Ethical ApprovalThis study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Inter-Department Ethics Committee A.O.U. Città della Salute e della Scienza, A.O. Ordine Mauriziano di Torino, and A.S.L. Città di Torino (Torino, Italy, number 0065839–00304/2020). Consent to ParticipateInformed consent was obtained from all individual participants included in the study. Competing interest The authors declare no competing interests. Conflict of interest The authors have no relevant financial or non-financial interests to disclose."

Evidence found in paper:

"Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025